Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
Sep 17, 2025, 8:00 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $230.97 million as of September 19, 2025. Its market cap has decreased by -74.36% in one year.
Market Cap
230.97M
Enterprise Value
116.82M
Revenue
27.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.60
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 230.97M, a decrease of -57.10%. That is a compound annual growth rate of -15.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 230.97M | -28.90% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 719.18M |
| Elite Pharmaceuticals | 697.08M |
| Glass House Brands | 575.59M |
| Northwest Biotherapeutics | 378.39M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 352.05M |
| American Oncology Network | 340.34M |